💵

Teleflex Incorporated

TFXDividend Payer
Healthcare · Medical Instruments & Supplies🇺🇸 United States
$136.29
Dividend Yield1.00%
Annual Dividend$1.37
Ex-Dividend DateAug 14, 2026
Market Cap$5.79B
45/ 100
Financial Health
Caution
⚠ Payout ratio 104% exceeds earnings⚠ Negative return on equityConservative leverage (D/E 1.0x)Revenue growing (29%)

Automated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.

At a glance

Teleflex Incorporated (TFX) operates in the Medical Instruments & Supplies industry and is based in the United States. It pays a quarterly dividend of $1.37 a year, a yield of 1.00% at the current price of $136.29. Over the last five years the dividend has grown by an average of 0.0% a year. It paid out 104% of its earnings as dividends, more than it earned. 12 analysts cover it; their average 12-month price target of $154.00 is 13.0% above the current price.

Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.

Price History
Dividend payment dates
Analyst Consensus
Buy
Bullish sentiment
50% of 12 analysts bullish
12-Month Price Target
$154.00
+13.0% vs current price

About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.

Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.

Key Metrics

Valuation

P/E Ratio
—
P/B Ratio
1.99
EV/EBITDA
20.8
Beta
0.83
vs S&P 500
52W High
$145.00
52W Low
$100.18

Profitability

Gross Margin
55.11%
Operating Margin
10.06%
Net Margin
-45.76%
ROE
-0.70%
Free Cash Flow
$179.5M

Financial Health

Debt / Equity
101.10
lower is safer
Current Ratio
2.60
>1 healthy
Quick Ratio
0.96
>1 healthy
Employees
15,500
HQ
Wayne, PA, United States
Data: Yahoo Finance (yfinance)|Updated: Oct 24, 2026 11:38

Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.

Legal Disclaimer

This website is not a financial advisor, investment advisor, or financial services provider. We do not offer, recommend, or imply any investment advice of any kind. We do not receive compensation, commissions, or any other benefit from any company, fund, financial product, or third party featured on this site. No content on this website constitutes a recommendation or solicitation to buy, sell, or hold any security or financial instrument.

All financial analysis, ratios, and written commentary are provided for educational and informational purposes only. The Financial Analysis and Financial Investigation sections reflect automated computations applied to publicly available financial data — they do not represent the opinion of a licensed financial professional. Always conduct your own independent research and consult a qualified, regulated financial adviser before making any investment decision. Past performance of dividends, prices, or earnings is not a guarantee of future results.

Data Sources: Yahoo Finance via yfinance (real-time prices, dividend history, financial statements, analyst ratings and price targets) · S&P 500 Dividend Aristocrats Index (official constituent list) · Dividend Kings public records (companies with 50+ years of consecutive dividend increases) · SEC EDGAR company filings (10-K annual reports — primary source for all financial statement data). Data is fetched automatically each day and may be delayed up to 24 hours. All figures are in USD unless otherwise stated.